本文已被：浏览 2620次 下载 1407次
Received:February 13, 2023 Published Online:March 20, 2023
Received:February 13, 2023 Published Online:March 20, 2023
中文摘要: 急性缺血性脑卒中(AIS)是我国致死和致残的第一大疾病。DEFUSE3和DAWN研究奠定了血管内治疗（EVT）在AIS诊疗中的地位。近年来，EVT在AIS中应用的相关研究捷报频传，越来越多的患者从中获益。本文从前循环卒中患者选择、围手术期管理和后循环血管内治疗三个方面对近年来的研究进展进行回顾，希望能为临床医师和相关科研人员提供参考。
Abstract:Acute ischemic stroke (AIS) is the leading cause of death and disability in China. DEFUSE3 and DAWN studies have established the status of intravascular therapy (EVT) in the diagnosis and treatment of AIS. In recent years, relevant research on the application of EVT in AIS is reported frequently, and more and more patients benefit from it. This article reviews the research progress in recent years from three aspects: selection of patients with anterior circulation stroke, perioperative management and posterior circulation intravascular treatment, hoping to provide reference for clinicians and relevant scientific researchers.
keywords: Acute ischemic stroke Endovascular treatment Intravenous thrombolysis Stent placement Stent retriever Perioperative management Blood pressure management Tirofiban Time window Posterior circulation stroke
文章编号： 中图分类号：R743.3 文献标志码：A
基金项目:国家自然科学基金项目（82103196）
| Author Name | Affiliation |
| ZHANG Xi, LI Jing-wei | Department of Neurology, Nanjing Drum Tower Hospital, Nanjing, Jiangsu 210008, China |
| 李敬伟 | 南京鼓楼医院神经内科，江苏 南京 210008 |
| Author Name | Affiliation |
| ZHANG Xi, LI Jing-wei | Department of Neurology, Nanjing Drum Tower Hospital, Nanjing, Jiangsu 210008, China |
| 李敬伟 | 南京鼓楼医院神经内科，江苏 南京 210008 |
引用文本：